Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BM7PE Immunotoxin in Colorectal Cancer Patients With Metastatic Disease
NCT04550897Phase 2Terminated
- Sponsor
- Oslo University Hospital
- Start
- Aug 2020
- Primary completion
- Jun 2024
- Modality
- Antibody-Drug Conjugates (ADCs), Immunotoxins, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of BM7PE in colorectal cancer (CRC), sponsored by Oslo University Hospital. Started Aug 2020; status: terminated.
02
Drugs
BM7PE
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT04550897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04550897.